Accolade Revenue and Competitors
Estimated Revenue & Valuation
- Accolade's estimated annual revenue is currently $230.5M per year.
- Accolade received $50.0M in venture funding in March 2018.
- Accolade's estimated revenue per employee is $128,837
- Accolade's total funding is $458.7M.
- Accolade's current valuation is $1.3B. (January 2022)
Employee Data
- Accolade has 1789 Employees.
- Accolade grew their employee count by 6% last year.
Accolade's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Actuary | Reveal Email/Phone |
2 | SVP, Product Management | Reveal Email/Phone |
3 | SVP - Product Management | Reveal Email/Phone |
4 | SVP, Operations | Reveal Email/Phone |
5 | SVP, GM Govt Solutions | Reveal Email/Phone |
6 | VP Customer Care | Reveal Email/Phone |
7 | VP, Customer Solutions | Reveal Email/Phone |
8 | VP, Financial Planning & Analysis | Reveal Email/Phone |
9 | VP, Clinical Operations | Reveal Email/Phone |
10 | VP, Solution Marketing | Reveal Email/Phone |
Accolade Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $197M | 1454 | -5% | $112.6M | $1.8B |
#2 | $6.9M | 57 | 12% | $4.9M | N/A |
#3 | $23.2M | 149 | -12% | $21.7M | N/A |
#4 | $3.8M | 36 | -3% | $308K | N/A |
#5 | $4.7M | 43 | -27% | $4.5M | N/A |
#6 | $4M | 63 | N/A | N/A | N/A |
#7 | $16.5M | 68 | N/A | N/A | N/A |
#8 | $21.8M | 145 | -9% | $55.5M | N/A |
#9 | $5.2M | 46 | -4% | N/A | N/A |
#10 | $0.3M | 4 | N/A | N/A | N/A |
#11 | $57.3M | 322 | -12% | $148.2M | N/A |
#12 | $5.2M | 49 | 32% | $1.2M | N/A |
#13 | $30.1M | 200 | -28% | $125M | N/A |
#14 | $76.7M | 423 | N/A | N/A | N/A |
#15 | $0.5M | 7 | N/A | N/A | N/A |
#16 | $3.1M | 19 | N/A | N/A | N/A |
#17 | $0.4M | 0 | N/A | $9.4M | N/A |
#18 | $0.3M | 4 | N/A | N/A | N/A |
#19 | $1.6M | 19 | N/A | N/A | N/A |
#20 | $4.6M | 41 | -5% | N/A | N/A |
What Is Accolade?
Accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. With a unique blend of compassionate advisors, clinical experts and intelligent technologies, we engage individuals and families in their health, establish trust, and influence their decisions at every stage of care. We've been recognized as one of the nation's 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500, and a top workplace by multiple news publications. For more information, visit www.accolade.com.
keywords:Healthcare
$458.7M
Total Funding
1789
Number of Employees
$230.5M
Revenue (est)
6%
Employee Growth %
$1.3B
Valuation
N/A
Accelerator
Accolade News
Creighton's Lommel grabs Big East Pitcher of the Week accolade. Trevor Maeder · Trevor Maeder · Author email. Apr 18, 2022; 5 hrs ago.
Accolade Inc (ACCD) stock has fallen 17.07% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.
... Smart looks to bring home a major accolade after he was officially nominated as a finalist for Defensive Player of the Year on Sunday.
Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based careLaunched Accolade One and Accol ...
Launched Accolade One and Accolade Care, two new healthcare solutions that combine Accolade's intelligent technology, advocacy services and team-based healthcare delivery SEATTLE, October 7, 2021 -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter en ...
Other Companies in Plymouth Meeting
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $810.8M | 2145 | 13% | N/A |
Accolade Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-03-30 | $50.0M | Undisclosed | Mutiple | Article |